Radiofrequency ablation for chronic knee, hip, and shoulder pain

CADTH
Record ID 32018005328
English
Authors' objectives: What is the clinical effectiveness of radiofrequency ablation for adults with chronic knee pain? What is the clinical effectiveness of radiofrequency ablation for adults with chronic hip pain?What is the clinical effectiveness of radiofrequency ablation for adults with chronic shoulder pain? What are the evidence-based guidelines regarding the use of radiofrequency ablation for adults with chronic knee, hip, or shoulder pain?
Authors' results and conclusions: For patients with knee osteoarthritis (OA), radiofrequency ablation may reduce pain and improve function compared to other nonsurgical interventions without increasing adverse events. There is insufficient evidence to suggest that radiofrequency ablation reduces pain or improves function among patients with chronic hip pain. We did not find any studies or guidelines on the clinical effectiveness of radiofrequency ablation for treating chronic shoulder pain that met the inclusion criteria for this review. Three guidelines conditionally recommend the use of radiofrequency ablation for patients with knee OA, and 1 guideline conditionally recommends the use of radiofrequency ablation for hip joint pain following diagnostic blocks.
Details
Project Status: Completed
URL for project: https://www.cadth.ca/radiofrequency-ablation-chronic-knee-hip-and-shoulder-pain
Year Published: 2023
URL for published report: https://www.cadth.ca/radiofrequency-ablation-chronic-knee-hip-and-shoulder-pain
English language abstract: An English language summary is available
Publication Type: Rapid Review
Country: Canada
MeSH Terms
  • Chronic Pain
  • Musculoskeletal Pain
  • Knee
  • Hip
  • Shoulder
  • Shoulder Pain
  • Radiofrequency Ablation
  • Radiofrequency Therapy
  • Osteoarthritis, Hip
  • Osteoarthritis, Knee
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: <p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.